Zhenyu Zhong Selected Research

Zhenyu Zhong Research Topics

Disease

15	Neoplasms (Cancer) 05/2022 - 10/2006
15	Inflammation (Inflammations) 05/2022 - 12/2006
9	Uveitis 01/2023 - 10/2020
8	Urinary Bladder Neoplasms (Bladder Cancer) 08/2022 - 01/2016
6	Neoplasm Metastasis (Metastasis) 08/2022 - 01/2016
6	Alzheimer Disease (Alzheimer's Disease) 01/2011 - 12/2005
5	Carcinogenesis 05/2022 - 09/2014
5	Infections 01/2022 - 01/2013
5	Carcinoma (Carcinomatosis) 10/2017 - 01/2016
3	Genetic Predisposition to Disease (Genetic Predisposition) 11/2023 - 01/2021
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2018
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2016
3	Cognitive Dysfunction 05/2008 - 12/2006
2	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 11/2023 - 01/2023
2	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 07/2016
2	COVID-19 01/2023 - 12/2022
2	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2017
2	Atrophy 01/2022 - 01/2011
2	Gout 07/2016 - 11/2013
2	Prostatic Neoplasms (Prostate Cancer) 05/2015 - 10/2006
1	Overnutrition 10/2023
1	Blau syndrome 01/2022
1	Congenital Abnormalities (Deformity) 01/2022
1	Multifocal Choroiditis 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Exanthema (Rash) 01/2022
1	Glaucoma 01/2022
1	Hepatitis 01/2022
1	Hepatitis B 01/2022
1	Papilledema 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Epiretinal Membrane (Epiretinal Membranes) 01/2022
1	Choroidal Neovascularization 01/2022
1	Behcet Syndrome (Behcet's Syndrome) 04/2021
1	Tuberculosis (Tuberculoses) 04/2021
1	Retinal Vasculitis 03/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2006
6	CytokinesIBA 10/2023 - 12/2014
6	InflammasomesIBA 05/2022 - 01/2013
5	Competitive Endogenous RNAIBA 08/2022 - 07/2016
4	Messenger RNA (mRNA)IBA 01/2023 - 07/2016
4	Circular RNAIBA 05/2022 - 01/2016
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 06/2007
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2023 - 03/2021
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 01/2022
3	Long Noncoding RNAIBA 08/2022 - 07/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
3	EnzymesIBA 01/2011 - 06/2007
2	HLA-A*26 antigenIBA 11/2023 - 01/2022
2	NF-kappa B (NF-kB)IBA 05/2022 - 08/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2021
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2021
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2022 - 03/2021
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 03/2021
2	Peptides (Polypeptides)IBA 01/2021 - 12/2006
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 01/2019
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 12/2014
2	Small Interfering RNA (siRNA)IBA 06/2018 - 01/2016
2	AntigensIBA 11/2017 - 05/2015
2	MicroRNAs (MicroRNA)IBA 12/2016 - 01/2016
2	Phosphotransferases (Kinase)IBA 01/2016 - 05/2015
2	Neutralizing AntibodiesIBA 12/2014 - 11/2013
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2011 - 06/2007
2	Amyloid beta-PeptidesIBA 05/2008 - 08/2007
1	HLA-B51 AntigenIBA 11/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2023
1	HLA-B15 AntigenIBA 11/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	Adalimumab (Humira)FDA Link 01/2023
1	GlucocorticoidsIBA 12/2022
1	COVID-19 VaccinesIBA 12/2022
1	antineoplaston A10 (A 10)IBA 10/2022
1	Air Pollutants (Pollutants, Air)IBA 10/2022
1	Transcription Factors (Transcription Factor)IBA 05/2022
1	ChemokinesIBA 05/2022
1	ChromatinIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Ranibizumab (Lucentis)FDA Link 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Fluocinolone Acetonide (Capex)FDA LinkGeneric 01/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022
1	LuciferasesIBA 01/2022
1	NucleotidesIBA 01/2022
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	ZincIBA 12/2021
1	CationsIBA 12/2021
1	Interleukin-23 (Interleukin 23)IBA 01/2021
1	SynucleinsIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	IgA receptor (protein B)IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021

Therapy/Procedure

9	Therapeutics 01/2022 - 11/2013
2	Drug Therapy (Chemotherapy) 05/2015 - 12/2014
1	Radiotherapy 01/2022
1	Chemoprevention 01/2022
1	Bariatric Surgery 01/2022
1	Nanospheres 01/2022